Besponsa 1mg Injection: Effective Treatment for Your Condition

Besponsa 1mg Injection

Uses:

• Treatment of acute lymphoblastic leukemia (ALL) in adults who have not responded to other treatments.

Therapeutic Effects:

• Targets a protein called CD22, commonly expressed by blood cancer (ALL) cells.
• Disturbs the DNA of cancer cells and kills them.

Important Safety Information:

• Allergies: Do not take if allergic to Inotuzumab ozogamicin or any other ingredients.
• Liver Disease: Contraindicated in patients with liver disease, such as venoocclusive disease, cirrhosis, nodular regenerative hyperplasia, or active hepatitis.
• Blood Clots: Not recommended for patients with blood clots.
• Children and Adolescents: Not recommended for use in children and adolescents.
• Pregnancy and Breastfeeding: Inform doctor if pregnant or planning to get pregnant. Use effective contraception during and after treatment.
• Driving: Avoid driving while taking this medication due to potential drowsiness.

Before Starting Treatment:

• Inform doctor about any signs and symptoms of tumor lysis syndrome, low blood cell counts, elevations in amylase or lipase enzymes, or a history of QT interval prolongation.
• Certain tests will be taken to monitor blood cell count, liver enzyme, and QT interval.

Interaction with Other Drugs:

• Inform healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional supplements, and herbal products.
• Certain medications may interact with Besponsa 1mg and reduce its effectiveness or cause undesirable side effects.

Storage:

• Store in the refrigerator (2°C to 8°C).
• Do not freeze.
• Keep away from the reach of children and pets.

Administration:

• Only a trained doctor or nurse should administer it.
• Do not self-administer.
• The doctor will decide the dose and duration of treatment based on disease severity and other factors.
• Given as an intravenous infusion, and you will be monitored carefully for unwanted side effects.

Side Effects:

• Serious: Breathing trouble, chills, rapid weight gain, abnormal liver function values, frequent bleeding and bruising, infusion-related reaction (fever, chill, breathing trouble), venoocclusive liver disease (rapid weight gain, right upper abdomen pain, swelling of the liver), lower number of blood cells, tumor lysis syndrome, changes in the electrical activity of the heart.
• Common: Anaemia, tiredness, infection, bleeding, fever, nausea, headache, abnormal blood values, stomach pain, high bilirubin value, low appetite, mouth inflammation, constipation, diarrhoea, swelling of abdomen.

FAQs:

• Q 1. Why is liver enzyme getting elevated during treatment with Besponsa 1mg? The reason for this elevation is not completely understood, but it is thought to be related to the drug's effects on certain enzymes involved in liver function.
• Q 2. Do we have to use contraception even after the treatment with Besponsa 1mg? Yes, it is advised to use effective contraception even after the last dose of Besponsa 1mg; 8 months for women and five months for men.
• Q 3. What should I inform the doctor about before starting the Besponsa 1mg? Inform about underlying medical conditions, especially the history of blood clots and liver-related conditions, before starting Besponsa 1mg.
• Q 4. Can I use Besponsa 1mg in children? No, only limited information is available about Besponsa 1mg usage in children. So it is advised not to use it in children. Talk to your doctor for more information.
• Q 5. Do we have to take any tests during Besponsa 1mg treatment? Yes, your physician might regularly take blood tests to monitor your blood count and liver enzymes. Additionally, an electrocardiogram will monitor your electrolyte during the treatment with Besponsa 1mg.

Fact Box:

• Molecule name: Inotuzumab ozogamicin
• Therapeutic class: Antineoplastic
• Pharmacological class: Monoclonal antibodies
• Indication: Acute lymphoblastic leukemia

Tags: medical-injection, besponsa-injection, pharmaceuticals, drugs, medicine, 1mg-injection